Triflusal
-
- Application
- Inhibition Assay (InhA), Functional Studies (Func)
- Purpose
- Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a drug of the salicylate family but it is not a derivative of acetylsalicylic acid (ASA).
- Characteristics
-
Source of Compound: synthetic
Target: TXA2 antagonist,PDE inhibitor
Receptor: PDE,TXA2R - Purification
- All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
- Purity
- 97 %
- Formula
- C10H7F3O4
- Solubility
- DMSO 50 mg/mL, Water <1 mg/mL
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Solid
- Storage
- -20 °C
- Storage Comment
-
For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
Several freeze/thaw cycles should not damage the activity of our small molecule products.
However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours. - Expiry Date
- 24 months
-
- Background
- Angiogenesis,Metabolism
- Molecular Weight
- 248.16 g/mol
- CAS-No
- 322-79-2
-